---
schema_version: "secwatch.filing_event.v1"
accession: "0001818093-22-000145"
form_type: "8-K"
ticker: "SKIN"
cik: "0001818093"
company_name: "SkinHealth Systems Inc."
filed_at: "2022-08-26T23:59:59+00:00"
generated_at: "2026-06-23T21:06:23.933607+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Stephan Becker, President of EMEA, leaves Beauty Health effective August 25, 2022

## Summary
- Stephan Becker, President of EMEA at The Beauty Health Company (SKIN), transitioned out effective August 25, 2022.
- Separation was not related to financial condition, reported results, internal controls, or disclosure controls.
- No successor or replacement was announced in the filing.

## SEC filing metadata
- accession: 0001818093-22-000145
- form_type: 8-K
- ticker: SKIN
- cik: 0001818093
- company_name: SkinHealth Systems Inc.
- filed_at: 2022-08-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818093/000181809322000145/0001818093-22-000145-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818093/000181809322000145/skin-20220825.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001818093-22-000145
- JSON: https://secwatch.observer/filing/0001818093-22-000145.json
- Plain text: https://secwatch.observer/filing/0001818093-22-000145.txt

## Key facts
- Executive change
  Stephan Becker changed role as President of EMEA at SkinHealth Systems Inc..
  - Action: transitioned out
  - Role: President of EMEA
  source text: Effective August 25, 2022, Stephan Becker, President of EMEA of The Beauty Health Company (the “Company”), has transitioned out of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818093/000181809322000145/0001818093-22-000145-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.